In lymphoma and other malignancies, EZH2 gain-of-function mutations and overexpression are considered important drivers of oncogenesis because of their role in silencing tumor suppressor genes regulating apoptosis, cell cycle regulation, proliferation, migration and differentiation [9–14]. Here, EZH2 is linked to neoplasm.